EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Moderate COVID‐19 Disease Is Associated With Reduced Bone Turnover

Katharina Kerschan-Schindl iD, Peter Dovjak, Maria Butylina, Anna Rainer, Bernhard Mayr, Veronika Röggla, Helmuth Haslacher, Michael Weber, Galateja Jordakieva, Peter Pietschmann iD

Journal of Bone and Mineral Research · 2023-07 · 38 (7) · 943-950

DOI: 10.1002/jbmr.4822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Mineral Research, online erschienen am 18.05.2023. Verfasst von Katharina Kerschan-Schindl und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Collagen Type I, COVID-19. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) infection has been associated with musculoskeletal manifestations, including a negative effect on bone health. Bone formation was found to be reduced in coronavirus disease 2019 (COVID‐19) patients. The aim of this case–control study was to determine whether bone metabolism is coupled or uncoupled in COVID‐19 patients with moderately severe disease, the latter expressed by the requirement of hospitalization but not intensive care treatment, no need for mechanical ventilation, and a C‐reactive protein level of (median [quartiles], 16.0 [4.0; 52.8]) mg/L in serum. Besides standard biochemical markers, serum levels of C‐terminal telopeptide of type 1 collagen, tartrate‐resistant acid phosphatase, osteocalcin, bone‐specific alkaline phosphatase, sclerostin, dickkopf‐1, and osteoprotegerin were evaluated in COVID‐19–infected patients at the time of hospital admission, along with those of age‐ and sex‐matched noninfected controls. The median age of the 14 female and 11 male infected patients included in the matched‐pair analysis was (67 [53; 81]) years. C‐terminal telopeptide of type 1 collagen was significantly lower in COVID‐19 patients (0.172 [0.097; 0.375] ng/mL) than in controls (0.462 [0.300; 0.649] ng/mL; p = 0.011). The patients' osteocalcin levels (10.50 [6.49; 16.26] ng/mL) were also lower than those of controls (15.33 [11.85, 19.63] ng/mL, p = 0.025). Serum levels of sclerostin and dickkopf‐1 were significantly higher in infected patients relative to controls. The remaining parameters did not differ between cases and controls. A limitation of the study was that patients and controls were recruited from different hospitals. Nevertheless, due to the geographical proximity of the two centers, we assume that this fact did not influence the results of the study. Given this limitation, the investigation showed that bone metabolism is altered but remains coupled in patients with moderately severe COVID‐19. Therefore, it is important to evaluate bone turnover markers and fracture risk in these patients during the postinfection period. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type ICOVID-19HumansMaleFemalePeptidesCase-Control StudiesOsteocalcinRNA, ViralSARS-CoV-2BiomarkersBone RemodelingBone Density

Stichwörter der Autor:innen

C-TERMINAL TELOPEPTIDE OF TYPE 1 COLLAGENOSTEOCALCIN

Substanzen

Collagen Type IPeptidesOsteocalcinRNA, ViralBiomarkers

Autor:innen und Institutionen

  • Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, Vienna, Austria.
  • Department of Acute Geriatrics, Salzkammergut Klinikum Gmunden, Gmunden, Austria.
  • Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Department of Internal Medicine, Salzkammergut Klinikum Gmunden, Gmunden, Austria.
  • Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Katharina Kerschan-Schindl, Peter Pietschmann

Zitieren

APA

Kerschan-Schindl, K., Dovjak, P., Butylina, M., Rainer, A., Mayr, B., Röggla, V., Haslacher, H., Weber, M., Jordakieva, G., & Pietschmann, P. (2023). Moderate COVID‐19 Disease Is Associated With Reduced Bone Turnover. Journal of Bone and Mineral Research, 38(7), 943-950. https://doi.org/10.1002/jbmr.4822

Vancouver

Kerschan-Schindl K, Dovjak P, Butylina M, Rainer A, Mayr B, Röggla V, et al. Moderate COVID‐19 Disease Is Associated With Reduced Bone Turnover. Journal of Bone and Mineral Research. 2023;38(7):943-950. doi:10.1002/jbmr.4822

BibTeX
@article{KerschanSchindl2023,
  author = {Kerschan-Schindl, Katharina and Dovjak, Peter and Butylina, Maria and Rainer, Anna and Mayr, Bernhard and Röggla, Veronika and Haslacher, Helmuth and Weber, Michael and Jordakieva, Galateja and Pietschmann, Peter},
  title = {Moderate COVID‐19 Disease Is Associated With Reduced Bone Turnover},
  journal = {Journal of Bone and Mineral Research},
  year = {2023},
  volume = {38},
  number = {7},
  pages = {943--950},
  doi = {10.1002/jbmr.4822}
}
Kostenlos starten →